BioCatalyst

Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab — catalyst calendar

1 verified catalyst event(s) referencing Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Comb
Phase 1/2 · Relapsed/Refractory Multiple Myeloma
 ONC BeOne Medicines Ltd. Sonrotoclax, Dexamethasone, Carfilzomib, ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.